Disciplines

Pharmaceutical Policy Analysis

Organizing institution
Utrecht University - Faculty of Science
Course code
M07
Course fee (excl. housing)
€ 975.00
Level
Advanced Master
Apply now!
This course will give students insight into current developments in pharmaceutical policy making. It will also give them a better understanding of the methods available for analysing the effects of policy interventions. It is an intensive programme covering the topics of pharmaceutical policy analysis issues and methods, current challenges in drug innovation, universal health coverage, regulatory issues and challenges, country profiles, policy and politics, synthesis, case studies and public health. As a collaborator on this course, the World Health Organization will provide lecturers for several of the sessions.
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

You will experience an intensive programme covering the following topics:
Pharmaceutical Policy Analysis issues and methods; current challenges in drug innovation; universal health coverage; regulatory issues and challenges; country profiles; policy and politics; synthesis, case studies & public health.
Download the day-to-day programme (PDF)

Course director

Dr. Aukje Mantel-Teeuwisse

Lecturers

Prof. Dr. Bert Leufkens, Dr. Gilles Forte (WHO), Dr. Aukje Mantel-Teeuwisse and other UU and WHO staff members.

Course aim

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

Study load

1 week full time

Fee

The course can be combined with the courses M8 - Pharmacoepidemiology and Drug Safety, M14 - Pharmacoeconomics and/or M34 Future Medicines: Gene & Cell Therapies to receive a discount. When combined with one of the other courses, the discount will be € 200.00 per course. When combined with two of the other courses, the discount will be € 300.00 per course. € 975.00
Housing € 200.00 , through Utrecht Summer School

The course can be combined with the courses M8 - Pharmacoepidemiology and Drug Safety, M14 - Pharmacoeconomics and/or M34 Future Medicines: Gene & Cell Therapies to receive a discount. When combined with one of the other courses, the discount will be € 200.00 per course. When combined with two of the other courses, the discount will be € 300.00 per course.

More information

Dr. Aukje Mantel P: +31 6 22 73 6017 E: a.k.mantel@uu.nl
Recommended combinations
Pharmacoepidemiology and Drug Safety
Pharmacoeconomics

Registration

Application deadline: 02 July 2018